Literature DB >> 2407634

Prognostic value of ovarian carcinoma grading methods--a method comparison study.

H Haapasalo1, Y Collan, A Seppä, A L Gidlund, N B Atkin, E Pesonen.   

Abstract

The prognostic value of subjective histological and morphometric grading was studied in 75 primary ovarian carcinomas. Histological grading methods recommended by Czernobilsky and by Russell and the morphometric method of Baak and co-workers were compared in a two-observer system. The 5-year survival could be correctly predicted in about two-thirds of the patients with all three methods. When mitotic counting (volume corrected mitotic index, M/V-index) was compared with the above grading methods by using a receiver operating characteristic curve) the M/V-index was generally superior in its prognostic power regardless of the sensitivity/specificity level chosen. The morphometric grading method and the grading method based on the M/V index were also shown to be readily reproducible.

Entities:  

Mesh:

Year:  1990        PMID: 2407634     DOI: 10.1111/j.1365-2559.1990.tb01053.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.

Authors: 
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

Review 3.  Laboratory handling of impalpable breast lesions: a review.

Authors:  J S Armstrong; J D Davies
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

4.  Nuclear grading of renal cell carcinomas--is morphometry necessary?

Authors:  K Donhuijsen; S Schulz; L D Leder
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma.

Authors:  C Q Liu; H Sasaki; M T Fahey; A Sakamoto; S Sato; T Tanaka
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.